<DOC>
	<DOCNO>NCT00862108</DOCNO>
	<brief_summary>The purpose study determine whether norepinephrine gene polymorphism affect treatment response ADHD</brief_summary>
	<brief_title>Methylphenidate Treatment Response Study Genetic Polymorphism Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>diagnosis make DSMIV KSADSPL IQ &gt; 71 genetic disorder history acquire brain injury seizure disorder neurologic disorder mental disorder , pervasive developmental disorder obsessiveCompulsive disorder communication disorder learn disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Polymorphism , Single Nucleotide</keyword>
	<keyword>SLC6A2 protein , human</keyword>
	<keyword>ADRA2A protein , human</keyword>
</DOC>